EGCG impedes human Tau aggregation and interacts with Tau

Tau aggregation and accumulation is a key event in the pathogenesis of Alzheimer’s disease. Inhibition of Tau aggregation is therefore a potential therapeutic strategy to ameliorate the disease. Phytochemicals are being highlighted as potential aggregation inhibitors. Epigallocatechin-3-gallate (EGC...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonawane, Shweta Kishor, Chidambaram, Hariharakrishnan, Boral, Debjyoti, Gorantla, Nalini Vijay, Balmik, Abhishek Ankur, Dangi, Abha, Ramasamy, Sureshkumar, Marelli, Udaya Kiran, Chinnathambi, Subashchandrabose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387440/
https://www.ncbi.nlm.nih.gov/pubmed/32724104
http://dx.doi.org/10.1038/s41598-020-69429-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387440/
https://www.ncbi.nlm.nih.gov/pubmed/32724104
http://dx.doi.org/10.1038/s41598-020-69429-6

Ejemplares similares